株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

輸液療法の世界市場:輸液手法別・輸液の種類別・用途別・5G向け活用法別・地域別の将来予測

Fluid Therapy Market - Forecast (2020 - 2025)

発行 IndustryARC 商品コード 850084
出版日 ページ情報 英文 106 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.09円で換算しております。
輸液療法の世界市場:輸液手法別・輸液の種類別・用途別・5G向け活用法別・地域別の将来予測 Fluid Therapy Market - Forecast (2020 - 2025)
出版日: 2020年03月11日 ページ情報: 英文 106 Pages
概要

当レポートでは、世界の輸液療法の市場について分析し、全体的な市場構造や背景事情、主な市場促進・抑制要因、新規参入の方法と容易性、輸液手法別・輸液の種類別・用途別・地域別の市場動向見通し (今後7年間分)、市場競争の構造、昨今の資本取引・戦略展開の動き、主要企業のプロファイルなどについて調査しております。

第1章 輸液療法:市場概要

第2章 輸液療法市場:エグゼクティブ・サマリー

第3章 輸液療法市場

  • 比較分析
    • 製品の相互比較:上位10社の場合
    • 上位5社の財務分析
    • 市場規模の内訳 (金額ベース):上位10社の場合
    • 特許分析:上位10社の場合
    • 価格動向の分析

第4章 輸液療法市場:スタートアップ企業のシナリオ

  • スタートアップ企業 (上位10社) の分析
    • 投資額
    • 市場収益額
    • 市場シェア
    • 市場規模・用途の分析
    • ベンチャーキャピタルと資金調達シナリオ

第5章 輸液療法市場:業界の市場参入シナリオ

  • 規制体制:概略
  • 新規ビジネスと「事業展開の容易性の指標」(Ease of Doing business index)
  • 事例研究:成功したベンチャー企業
  • 顧客分析:上位10社の場合

第6章 輸液療法市場の影響要因

  • 市場の促進要因
  • 市場の抑制要因・課題
  • ポーターのファイブフォース分析

第7章 輸液療法市場:戦略分析

  • バリューチェーン分析
  • 市場機会の分析
  • 製品ライフサイクル
  • サプライヤー/流通業者の市場シェア

第8章 輸液療法市場:治療法別

  • イントロダクション
  • 人間向け
    • 維持療法
    • 輸液蘇生

第9章 輸液療法市場:輸液手法別

  • イントロダクション
  • 人間向け
    • 経口輸液
    • 皮下輸液
    • 静脈内輸液
    • 骨髄内輸液
  • 動物向け
    • 経口輸液
    • 皮下輸液
    • 腹腔内輸液
    • 静脈内輸液
    • 骨髄内輸液
    • その他

第10章 輸液療法市場:輸液の種類別

  • イントロダクション
  • 人間向け
    • コロイド
    • クリスタロイド
      • 等浸透圧 (アイソトニック)
      • 低浸透圧 (ハイポトニック)
      • 高浸透圧 (ハイパートニック)
    • 血液・血液製剤
  • 動物向け
    • コロイド
      • 天然
      • 合成
    • クリスタロイド
      • 等浸透圧 (アイソトニック)
      • 低浸透圧 (ハイポトニック)
      • 高浸透圧 (ハイパートニック)

第11章 輸液療法市場:用途別

  • イントロダクション
  • 人間向け
    • 麻酔
    • 心肺蘇生 (CPR)
    • 鬱血性心不全 (CHF)
    • 輸液
    • 高張食塩水
    • その他
  • 動物向け
    • 麻酔
    • 貧血症
    • 下痢
    • 血液量減少症
    • 心臓疾患
    • その他

第12章 輸液療法市場:地域別

  • イントロダクション
  • 北米市場
    • 米国、カナダ、メキシコなど
  • 南米市場
    • ブラジル、ベネズエラ、アルゼンチン、エクアドル、ペルー、コロンビア、コスタリカなど
  • 欧州市場
    • フランス、デンマーク、ドイツ、スペイン、ベルギー、英国、イタリア、オランダなど
  • アジア太平洋地域市場
    • 中国、インド、日本、韓国、オーストラリア・ニュージーランド、台湾、マレーシアなど
  • 他の国々の市場 (RoW:中東・アフリカ)

第13章 輸液療法市場:市場変化の方向性

  • 新製品の発売
  • 企業合併・買収 (M&A)、事業協力・提携、合弁事業 (JV)

第14章 輸液療法市場:産業別/分野別の競合情勢

  • 市場シェア分析
    • 国別の市場シェア:大手企業の場合
    • 地域別の市場シェア:上位10社の場合
    • 用途別の市場シェア:上位10社の場合
    • 製品/製品カテゴリー別の市場シェア:上位10社の場合
    • 世界全体の市場シェア:上位10社の場合
    • 各種企業にとってのベストプラクティス

第15章 主要企業の一覧:国別

第16章 企業分析

  • 市場シェア、企業収益額、主要製品、企業合併・買収 (M&A)、近年の動向
  • Baxter International, Inc. (米国)
  • B. Braun Melsungen AG (ドイツ)
  • Fresenius Kabi AG (ドイツ)
  • Dechra Veterinary Products, LLC (米国)
  • D.J. Laboratories Pvt. Ltd (インド)
  • Animalcare Ltd. (英国)
  • ICU Medical (米国)
  • その他

第17章 付録

第18章 分析手法

目次
Product Code: HCR 1264

Fluid Therapy Market Overview

Fluid therapy is involves infusing crystalloid solutions into patients who are hypovolemic, or in cases of dehydration to replace ongoing fluid losses and meet the fluid requirements of patients who cannot take fluids orally. The Fluid Therapy market has been segmented on the basis of therapy type, routes of fluid administration, types of fluids, by application, and by geographic regions.

Different types of fluids such as colloidal solutions, crystalloid solutions, and blood products are used during fluid therapy. Administration of these fluids is done by using different routes such as oral, subcutaneous, intravenous, intraosseous, and so on. The fluid therapy market generated revenue of $7,297m in 2017 and is estimated to exceed $10,559m by 2023, growing at an estimated CAGR of 6.4%.

Fluid Therapy Market Outlook

The global Fluid Therapy market has been witnessing a brisk growth in the recent years owing to increased incidences of chronic diseases related to nephrology, gastrointestinal tract, heart failures, cancer and diabetes. Fluid therapy is used to treat disorders such as sepsis, colic, hypovolemia and shock. Innovative products and services can help physicians and doctors protect both humans and animals from such diseases. The human segment accounted for 78% of the total market share in 2017.

Colloids and crystalloids are the types of fluids uses in fluid therapy to maintain or restore the vascular volume and tissue perfusion in humans and animals. In humans, at times, blood and blood products are also intravenously administered to restore circulation to vital organs following loss of intravascular volume due to bleeding, plasma loss, and so on. North America dominated the Fluid Therapy Market with 33% of the overall market revenue in 2017. The Asia-Pacific region forecast to be the fastest growing market for fluid therapy. The region's market is estimated to grow at a CAGR of 7.4% during the forecast period 2018-2023.

Fluid Therapy Market Growth Drivers

Increased awareness among people about fitness and health issues and their urge to take preventive steps to avoid chronic diseases are the major factors driving the market for fluid therapy. The rise in demand for maintenance therapy using colloids and crystalloids is also boosting the market for fluid therapy. Due to rapid urbanization, and sedentary lifestyle of people, there has been an exponential rise in chronic diseases such as cancer, diabetes, CVDs, arthritis, COPD, and diabetes. Thus, the demand for intravenous fluid therapy is increasing rapidly.

Fluid Therapy Market Challenges

Plastic contaminants have been found in blood products stored for long periods in bags. Frequent use of such solvable plastics in high doses can harm patients and research laboratory animals. Plastic bags can leach toxic chemicals into patients' veins. So, this is a major constraint for the fluid therapy market.

Strigent regulations regarding the approvals of medical devices use in fluid therapy and high costs associated with the treatment are hindering the growth of fluid therapy market

Fluid Therapy Market Research Scope

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the fluid therapy market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of fluid therapy and fluids, and their specific applications.

Fluid Therapy Market Report: Industry Coverage

Fluid Therapy Market - By Therapy: Maintenance Therapy and Fluid Resuscitation

Fluid Therapy Market - By Routes of Fluid Administration: Oral, Subcutaneous, Intravenous, Intraosseous, Intraperitoneal and Others

Fluid Therapy Market - By Types of Fluids: Colloids, Crystalloids, Blood & Blood Products and Others

Fluid Therapy Market - By Application: Human and Animals

The Fluid Therapy market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia & New Zealand, South Korea, India, Taiwan, Malaysia

Middle East and Africa: Israel, South Africa, Saudi Arabia

Fluid Therapy Market Key Players

Some of the key players mentioned in this market research report include Baxter International, Inc. (the U.S.), B. Braun Melsungen AG (Germany) Fresenius Kabi AG (Germany), Dechra Veterinary Products, LLC (the U.S.), D.J. Laboratories Pvt. Ltd (India), Animalcare Ltd. (the U.K.), and ICU Medical (the U.S.).

Fluid Therapy Market Trends

Patient's fast recovery owing to fluid therapy is providing opportunities to the market players to manufacture innovative products, which drives the market growth.

The global market for fluid therapy is well established and its growth can be accredited to the growing health awareness and an increase in chronic diseases in the past few years.

North America dominated the fluid therapy market with a share of 33% of the total market value in 2017. The market in North America was valued at $2,386 m in 2017 and is estimated to reach $3,516m by 2023.

Innovative fluid therapy products are more helpful to nurses in case of treatment, thus providing manufacturers an opportunity to attract end users and enhance their market share

1. Fluid Therapy Market - Overview

  • 1.1. Definitions and Scope

2. Fluid Therapy Market - Executive Summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Fluid Therapy Market - Market Landscape

  • 3.1. Comparative Analysis
    • 3.1.1. Product Benchmarking - Top 10 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 10 companies
    • 3.1.4. Patent Analysis - Top 10 companies
    • 3.1.5. Pricing Analysis

4. Fluid Therapy Market - Market Forces

  • 4.1. Drivers
  • 4.2. Constraints & Challenges
  • 4.3. Porters five force model
    • 4.3.1. Bargaining power of suppliers
    • 4.3.2. Bargaining powers of customers
    • 4.3.3. Threat of new entrants
    • 4.3.4. Rivalry among existing players
    • 4.3.5. Threat of substitutes

5. Fluid Therapy Market - Strategic Analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product/Market Life Cycle Analysis
  • 5.4. Suppliers and distributors Market Share

6. Fluid Therapy Market - By Therapy

  • 6.1. Introduction
  • 6.2. Human
    • 6.2.1. Maintenance Therapy
    • 6.2.2. Fluid Resuscitation

7. Fluid Therapy Market - By Route of Fluid Administration

  • 7.1. Introduction
  • 7.2. Human
    • 7.2.1. Oral
    • 7.2.2. Subcutaneous
    • 7.2.3. Intravenous
    • 7.2.4. Intraosseous
    • 7.2.5. Others
  • 7.3. Animal
    • 7.3.1. Oral
    • 7.3.2. Subcutaneous
    • 7.3.3. Intraperitoneal
    • 7.3.4. Intravenous
    • 7.3.5. Intraosseous
    • 7.3.6. Others

8. Fluid Therapy Market - By Type of Fluid

  • 8.1. Introduction
  • 8.2. Human
    • 8.2.1. Colloids
    • 8.2.2. Crystalloids
      • 8.2.2.1. Isotonic
      • 8.2.2.2. Hypotonic
      • 8.2.2.3. Hypertonic
    • 8.2.3. Blood & Blood Products
  • 8.3. Animal
    • 8.3.1. Colloids
      • 8.3.1.1. Natural
      • 8.3.1.2. Synthetic
    • 8.3.2. Crystalloids
      • 8.3.2.1. Isotonic
      • 8.3.2.2. Hypotonic
      • 8.3.2.3. Hypertonic

9. Fluid Therapy Market - By Application

  • 9.1. Introduction
  • 9.2. Human
    • 9.2.1. Anesthesia
    • 9.2.2. Cardiopulmonary Resuscitation (CPR)
    • 9.2.3. Congestive Heart Failure (CHF)
    • 9.2.4. Fluids and Transfusions
    • 9.2.5. Hypertonic Saline
    • 9.2.6. Others
  • 9.3. Animal
    • 9.3.1. Anesthesia
    • 9.3.2. Anemia
    • 9.3.3. Diarrhea
    • 9.3.4. Hypovolemia
    • 9.3.5. Cardiac Disease
    • 9.3.6. Others

10. Fluid Therapy Market - By Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. South America
    • 10.3.1. Brazil
    • 10.3.2. Venezuela
    • 10.3.3. Argentina
    • 10.3.4. Ecuador
    • 10.3.5. Peru
    • 10.3.6. Colombia
    • 10.3.7. Costa Rica
    • 10.3.8. Rest of South America
  • 10.4. Europe
    • 10.4.1. France
    • 10.4.2. Denmark
    • 10.4.3. Germany
    • 10.4.4. Spain
    • 10.4.5. Belgium
    • 10.4.6. U.K.
    • 10.4.7. Italy
    • 10.4.8. The Netherlands
    • 10.4.9. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. China
    • 10.5.2. India
    • 10.5.3. Japan
    • 10.5.4. South Korea
    • 10.5.5. Australia & New Zealand
    • 10.5.6. Taiwan
    • 10.5.7. Malaysia
    • 10.5.8. Rest of Asia-Pacific
  • 10.6. Rest of the World
    • 10.6.1. Middle East
    • 10.6.2. Africa

11. Fluid Therapy Market - Market Entropy

  • 11.1. New product launches
  • 11.2. M&A, Collaboration, Partnerships, & JVs

12. Fluid Therapy Market Company Analysis

  • 12.1. Market Share, Company Revenue, Products, M&A, Developments
  • 12.2. Baxter International, Inc. (the U.S.)
  • 12.3. B. Braun Melsungen AG (Germany)
  • 12.4. Fresenius Kabi AG (Germany)
  • 12.5. Dechra Veterinary Products, LLC (the U.S.)
  • 12.6. D.J. Laboratories Pvt. Ltd (India)
  • 12.7. Animalcare Ltd. (the U.K.)
  • 12.8. ICU Medical (the U.S.)
  • 12.9. Company 8
  • 12.10. Company 9
  • 12.11. Company 10 and more

"*Financials would be provided on a best efforts basis for private companies"

13. Fluid Therapy Market -Appendix

  • 13.1. Abbreviations
  • 13.2. Sources